Introduction
Saad Alam was in his mid-thirties, physically active, and sleeping well when he began gaining weight and feeling depressed. When he raised the issue with a physician, the response left him unconvinced: the doctor attributed it to early aging for South Asian men and prescribed Viagra and an antidepressant. Alam pushed for more answers. After consulting endocrinologists, urologists, and cardiologists, he learned his testosterone levels were low. That personal health journey led him to cofound Hone Health in 2020, an online clinic focused initially on men's hormone health.
What Happened
Six years after its founding, Hone Health announced $228 million in fresh financing. The equity portion totals $28 million and is led by MarcyPen Capital Partners, the firm tied to Shawn "Jay-Z" Carter, Jay Brown, Robbie Robinson, and D'Rita Robinson. MarcyPen had previously led Hone's Series A, a fact the company had not disclosed until now. The round also includes Kinship Ventures, cofounded by Gwyneth Paltrow and Moj Mahdara, along with Pentland Ventures, Hanwha, Gannet Capital, and Humbition. Notable individual backers include the Jonas Brothers, Kelly Rowland, Marcello Hernández, David Grutman, Jason Strauss, Noah Tepperberg, and Quentin Dolan.
Paltrow is not just an investor; she is also a patient, saying she completed lab work and began a protocol that addressed gut bacteria and hormone imbalances. The remaining $200 million comes from General Catalyst's Customer Value Fund, a revenue-based facility that covers sales and marketing costs and is repaid from the profits generated by newly acquired patients. Hone says it has surpassed $100 million in annual recurring revenue and has treated roughly 200,000 people since launch. Total equity funding now stands at $65 million.
Alongside the funding news, Hone is introducing Hone Black, a concierge membership that has operated quietly for a small group of high-profile clients. It offers testing across more than 1,600 health markers with a dedicated medical team. The company also revealed it is the first business under a parent organization called Time Therapeutics, which aims to run remote clinical trials and partner with drugmakers.
Why This Matters
The investment signals strong confidence in direct-to-consumer men's health and data-driven preventive care. By using artificial intelligence to let a single physician manage cases that would normally require multiple specialists, Hone is attempting to scale personalized medicine without a proportional increase in staffing. The involvement of celebrities and athletes also brings mainstream attention to hormone health and longevity, areas that have historically been niche or stigmatized.
The financing structure is equally noteworthy. Rather than a traditional equity Series B, most of the capital is structured as revenue-based funding, meaning repayment is tied to patient acquisition results rather than fixed debt obligations. This model aligns investor returns with growth, though it depends on steady patient retention.
Key Takeaways
- Hone Health raised $228 million, with $28 million in equity led by MarcyPen Capital Partners.
- Gwyneth Paltrow is both an investor and a patient at the clinic.
- General Catalyst provided $200 million through a revenue-based sales and marketing fund.
- The company has treated about 200,000 patients and exceeded $100 million in recurring revenue.
- A new concierge tier, Hone Black, offers extensive biomarker testing for high-profile clients.
- Hone operates under Time Therapeutics, with plans for remote clinical trials and pharmaceutical partnerships.
Conclusion
Hone Health's latest funding round reflects growing investor appetite for digital health platforms that combine telemedicine, hormone treatment, and preventive longevity services. With backing from MarcyPen, Paltrow, and General Catalyst, the company plans to deepen its AI capabilities, expand its concierge offering, and eventually move into clinical research through its parent company. Whether this model can scale while maintaining quality of care remains to be seen, but the capital infusion gives Hone significant resources to try.

Discussion
Join the conversation
Thoughtful reactions, questions, and follow-up ideas help shape the next story.